A/Prof Kat Holt |
Monash University as a whole has been awarded almost $76 million in the latest round of NHMRC funding.
Federal Health Minister, the Hon. Greg Hunt, today announced over $500 million across 682 health and medical research grants through the NHMRC and the Medical Research Future Fund (MRFF).
Monash attracted the most funding nationally bringing this year’s total to over $104 million in federal grants for medical and health research projects.
Monash attracted funding across six of the eight schemes announced today – Project Grants (74), Postgraduate Scholarships (11), TRIP Fellowships (6), Partnership Project Grants (1), Equipment Grant (1) and International Collaboration (1).
As we all know, the process is intensely competitive and many great research projects didn't make the cut. Hang in there! In addition to the CCS based recipients listed below, we would also like to congratulate A/Prof Kat Holt who received a grant and is currently at the University of Melbourne. Kat will be joining the Department of Infectious Diseases in 2019.
CIA Name
|
Grant Title
|
TOTAL
|
|
Prof Rob Medcalf
Australian Centre for Blood Diseases |
Improving the safety and predictable efficacy of thrombolytic therapy in acute ischaemic stroke
|
$1,371,900
|
|
Dr Vilijia Jokubaitis
Department of Neuroscience |
Multiple Sclerosis: Pregnancy and prognosis
|
$470,078.80
|
|
A/Prof Nigel Jones
Department of Neuroscience |
Functional disconnections in schizophrenia
Antidepressants in epilepsy
|
$642,012.60
$1,023,118.70
|
|
Dr Andrew Stewardson
Department of Infectious Diseases |
Understanding Patient Movement Networks to better prevent dissemination of antimicrobial resistance
|
$409,719.90
|
|
Prof Karin Jandeleit-Dahm
|
Targeting Nox5 to prevent atherosclerosis and aneurysm formation
Lipoxins protect against diabetes associated atherosclerosis
|
$993,742
$936,759.20
|
|
Dr Andrew Wei
|
Transforming the treatment landscape in elderly Acute Myeloid Leukaemia
|
$1,071,166
|
|
Prof David Tarlinton
Department of Immunology and Pathology |
The dynamics of determinants of plasma cell revival
|
$859,702
|
|
Prof David Curtis
Australian Centre for Blood Diseases |
Target therapies for chemo-resistant leukaemia cells
|
$727,087
|
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.